BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12455043)

  • 1. Effect of treatment sequence with radiotherapy and the antiestrogen EM 800 on the growth of ZR 75 1 human mammary carcinoma in nude mice.
    Gutman M; Couillard S; Labrie F; Candas B; Labrie C
    Int J Cancer; 2003 Jan; 103(2):268-76. PubMed ID: 12455043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined treatment with the pure antiestrogen EM-800 and radiotherapy on the growth of human ZR-75-1 breast cancer xenografts in nude mice.
    Couillard S; Gutman M; Labrie F; Candas B; Labrie C
    Cancer Res; 1999 Oct; 59(19):4857-63. PubMed ID: 10519396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the antiestrogen EM-800 (SCH 57050) and cyclophosphamide alone and in combination on growth of human ZR-75-1 breast cancer xenografts in nude mice.
    Gutman M; Couillard S; Labrie F; Candas B; Labrie C
    Cancer Res; 1999 Oct; 59(20):5176-80. PubMed ID: 10537294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts.
    Couillard S; Labrie C; Bélanger A; Candas B; Pouliot F; Labrie F
    J Natl Cancer Inst; 1998 May; 90(10):772-8. PubMed ID: 9605648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.
    Luo S; Sourla A; Labrie C; Bélanger A; Labrie F
    Endocrinology; 1997 Oct; 138(10):4435-44. PubMed ID: 9322961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term inhibitory effect of the orally active and pure antiestrogen EM-800 on the growth of human breast cancer xenografts in nude mice.
    Couillard S; Labrie C; Gauthier S; Merand Y; Singh SM; Candas B; Labrie F
    Int J Cancer; 2000 Feb; 85(3):424-9. PubMed ID: 10652436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice.
    Luo S; Sourla A; Labrie C; Gauthier S; Merand Y; Belanger A; Labrie F
    Endocrinology; 1998 May; 139(5):2645-56. PubMed ID: 9564882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of the antiestrogens EM-800 and tamoxifen on the growth of human breast ZR-75-1 cancer xenografts in nude mice.
    Couillard S; Gutman M; Labrie C; Bélanger A; Candas B; Labrie F
    Cancer Res; 1998 Jan; 58(1):60-4. PubMed ID: 9426058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050).
    Luo S; Labrie C; Bélanger A; Candas B; Labrie F
    Breast Cancer Res Treat; 1998 May; 49(1):1-11. PubMed ID: 9694606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice.
    Dauvois S; Geng CS; Lévesque C; Mérand Y; Labrie F
    Cancer Res; 1991 Jun; 51(12):3131-5. PubMed ID: 2039992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
    Gutman M; Couillard S; Roy J; Labrie F; Candas B; Labrie C
    Int J Cancer; 2002 May; 99(2):273-8. PubMed ID: 11979444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800.
    Sourla A; Luo S; Labrie C; Bélanger A; Labrie F
    Endocrinology; 1997 Dec; 138(12):5605-17. PubMed ID: 9389549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
    Kirichenko AV; Rich TA; Newman RA; Travis EL
    Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo biologic evaluation of long-circulating biodegradable drug carriers loaded with the pure antiestrogen RU 58668.
    Ameller T; Marsaud V; Legrand P; Gref R; Renoir JM
    Int J Cancer; 2003 Sep; 106(3):446-54. PubMed ID: 12845687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse.
    Martel C; Labrie C; Bélanger A; Gauthier S; Mérand Y; Li X; Provencher L; Candas B; Labrie F
    Endocrinology; 1998 May; 139(5):2486-92. PubMed ID: 9564862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.
    Kleibeuker EA; Fokas E; Allen PD; Kersemans V; Griffioen AW; Beech J; Im JH; Smart SC; Castricum KC; van den Berg J; Schulkens IA; Hill SA; Harris AL; Slotman BJ; Verheul HM; Muschel RJ; Thijssen VL
    Oncotarget; 2016 Nov; 7(47):76613-76627. PubMed ID: 27780936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of raloxifene and the active metabolite of the antiestrogen EM-800 (SC 5705) with the human estrogen receptor.
    Schafer JI; Liu H; Tonetti DA; Jordan VC
    Cancer Res; 1999 Sep; 59(17):4308-13. PubMed ID: 10485477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.